LIGAND PHARMACEUTICALS INC LGND 0.75 05.15.23
NOTE 0.750% 5/1 · US DOMESTIC · CUSIP 53220KAF5
1
institutional holders
-26 vs Q1 2023
$300.0kprincipal reported held*
$298.7kreported value*
0 new
0 added
0 reduced
26 sold out
net sold ≈ $71.2m (-5.2m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 24 |
| Q4 2022 | 26 |
| Q1 2023 | 27 |
| Q2 2023 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 8 | 5 |
| Q1 2023 | 6 | 4 |
| Q2 2023 | 0 | 26 |
Biggest buyers
| None |
Biggest sellers
| OAKTREE CAPITAL MANAGEMENT LP | Sold out | -10.7m |
| RiverPark Advisors, LLC | Sold out | -9.9m |
| Cohanzick Management, LLC | Sold out | -9.9m |
| CAPSTONE INVESTMENT ADVISORS, LLC | Sold out | -7.5m |
| PALISADE CAPITAL MANAGEMENT, LP | Sold out | -6.3m |
| VOYA INVESTMENT MANAGEMENT LLC | Sold out | -5.0m |
| WESTWOOD HOLDINGS GROUP INC | Sold out | -4.0m |
| Radcliffe Capital Management, L.P. | Sold out | -3.1m |
| SCHRODER INVESTMENT MANAGEMENT GROUP | Sold out | -3.0m |
| Russell Investments Group, Ltd. | Sold out | -2.5m |
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.00% of their portfolio | 300.0k $298.7k | Unchanged |